Daniel R. Hart
2021
Compensation breakdown
| Bonus | $116,112 |
|---|---|
| Non-Equity Incentive Plan | $310,624 |
| Option Awards | $315,054 |
| Salary | $423,698 |
| Stock Awards | $135,004 |
| Other | $48,846 |
| Total | $1,349,338 |
Hart received $423.7K in salary, accounting for 31% of the total pay in 2021.
Hart also received $116.1K in bonus, $310.6K in non-equity incentive plan, $315.1K in option awards, $135K in stock awards and $48.8K in other compensation.
Rankings
In 2021, Daniel R. Hart's compensation ranked 7,672nd out of 12,415 executives tracked by ExecPay. In other words, Hart earned more than 38.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,672 out of 12,415 | 38th |
Division Manufacturing | 3,380 out of 5,505 | 39th |
Major group Chemicals And Allied Products | 1,496 out of 2,375 | 37th |
Industry group Drugs | 1,330 out of 2,096 | 37th |
Industry Pharmaceutical Preparations | 982 out of 1,546 | 37th |
Pay ratio
| Daniel R. Hart's Pay | $1,349,338 |
|---|---|
| Median Employee's Pay | $104,222 |
| Pay Ratio | 13to 1 |
In 2021, the annual total compensation of Daniel R. Hart was $1,349,338.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,222.
The ratio of Daniel R. Hart's pay to the pay of median employee was therefore 13 to one.
Hart's colleagues
We found three more compensation records of executives who worked with Daniel R. Hart at Peregrine Pharmaceuticals in 2021.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019